These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 28246467)

  • 21. Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.
    Mastoraki A; Chatzimavridou-Grigoriadou V; Chatzipetrou V; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
    J Gastrointest Cancer; 2014 Sep; 45(3):256-61. PubMed ID: 24756831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
    Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
    Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.
    Matsubayashi H; Kiyozumi Y; Ishiwatari H; Uesaka K; Kikuyama M; Ono H
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31683730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
    Torphy RJ; Schulick RD
    Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
    Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
    Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
    Sheel ARG; Harrison S; Sarantitis I; Nicholson JA; Hanna T; Grocock C; Raraty M; Ramesh J; Farooq A; Costello E; Jackson R; Chapman M; Smith A; Carter R; Mckay C; Hamady Z; Aithal GP; Mountford R; Ghaneh P; Hammel P; Lerch MM; Halloran C; Pereira SP; Greenhalf W
    Am J Gastroenterol; 2019 Jan; 114(1):155-164. PubMed ID: 30353057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial pancreatic cancer.
    Rieder H; Bartsch DK
    Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
    Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pancreatic cancer--current knowledge.
    Bartsch DK; Gress TM; Langer P
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary pancreatic cancer].
    Habbe N; Langer P; Bartsch DK
    Chirurg; 2008 Nov; 79(11):1029-37. PubMed ID: 18818893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial Pancreatic Adenocarcinoma.
    Petersen GM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):641-53. PubMed ID: 26226902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of age of onset in pancreatic cancer kindreds.
    Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
    J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
    Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A histomorphologic comparison of familial and sporadic pancreatic cancers.
    Singhi AD; Ishida H; Ali SZ; Goggins M; Canto M; Wolfgang C; Meriden Z; Roberts N; Klein AP; Hruban RH
    Pancreatology; 2015; 15(4):387-391. PubMed ID: 25959245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
    Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
    Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.